IL150512A0 - Process for making geminal bisphosphonates - Google Patents

Process for making geminal bisphosphonates

Info

Publication number
IL150512A0
IL150512A0 IL15051201A IL15051201A IL150512A0 IL 150512 A0 IL150512 A0 IL 150512A0 IL 15051201 A IL15051201 A IL 15051201A IL 15051201 A IL15051201 A IL 15051201A IL 150512 A0 IL150512 A0 IL 150512A0
Authority
IL
Israel
Prior art keywords
substituted
unsubstituted
unsaturated
saturated
hydrogen
Prior art date
Application number
IL15051201A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IL150512A0 publication Critical patent/IL150512A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3873Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/386Polyphosphonic acids containing hydroxy substituents in the hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15051201A 2000-02-01 2001-02-01 Process for making geminal bisphosphonates IL150512A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17950600P 2000-02-01 2000-02-01
PCT/US2001/003309 WO2001057052A1 (fr) 2000-02-01 2001-02-01 Fabrication de biphosphonates gemines

Publications (1)

Publication Number Publication Date
IL150512A0 true IL150512A0 (en) 2003-02-12

Family

ID=22656872

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15051201A IL150512A0 (en) 2000-02-01 2001-02-01 Process for making geminal bisphosphonates
IL150512A IL150512A (en) 2000-02-01 2002-07-01 Process for the preparation of geminal bisphosphonates

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL150512A IL150512A (en) 2000-02-01 2002-07-01 Process for the preparation of geminal bisphosphonates

Country Status (27)

Country Link
US (1) US6562974B2 (fr)
EP (1) EP1252169B1 (fr)
JP (1) JP4534185B2 (fr)
KR (1) KR100681740B1 (fr)
CN (1) CN1223598C (fr)
AT (1) ATE269343T1 (fr)
AU (1) AU784385B2 (fr)
BR (1) BRPI0107952B8 (fr)
CA (1) CA2399974C (fr)
CO (1) CO5430222A1 (fr)
CZ (1) CZ304038B6 (fr)
DE (1) DE60103851T2 (fr)
DK (1) DK1252169T3 (fr)
ES (1) ES2221887T3 (fr)
HK (1) HK1051045A1 (fr)
HU (1) HU228980B1 (fr)
IL (2) IL150512A0 (fr)
MX (1) MXPA02007418A (fr)
NO (1) NO330273B1 (fr)
NZ (1) NZ519967A (fr)
PE (1) PE20011065A1 (fr)
PL (1) PL207617B1 (fr)
PT (1) PT1252169E (fr)
RU (1) RU2002123362A (fr)
SK (1) SK10992002A3 (fr)
TR (1) TR200402317T4 (fr)
WO (1) WO2001057052A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2347330C (fr) * 2001-05-10 2002-03-12 Pharmaceutical Partners Of Canada Inc. Preparation injectable liquide de pamidronate disodique
GB0115824D0 (en) * 2001-06-28 2001-08-22 Rhodia Cons Spec Ltd Improved solvent systems
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
EP1465606A4 (fr) * 2001-12-24 2009-04-22 Teva Pharma Forme posologique avec pastille noyau de principe actif enrobee dans un corps annulaire comprime de poudre ou de substance granulaire, et procede et outils pour la production de cette forme posologique
ITMI20020908A1 (it) * 2002-04-29 2003-10-29 Chemi Spa Processo di preparazione di sodio alendronato
CA2485443C (fr) 2002-05-17 2010-04-06 Teva Pharmaceutical Industries Ltd Utilisation d'hydrocarbures aromatiques et d'huiles de silicone pour la preparation d'acides bisphosphoniques
EP1656386B1 (fr) 2003-08-21 2009-12-09 Sun Pharmaceuticals Industries Ltd. Procede d'elaboration de composes d'acide bisphosphonique
US20050260272A1 (en) * 2004-05-05 2005-11-24 Alkermes Controlled Therapeutics, Inc. Method of forming microparticles that include a bisphosphonate and a polymer
US7358361B2 (en) * 2004-10-08 2008-04-15 The Board Of Trustees Of The University Of Illinois Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
US8012949B2 (en) * 2004-10-08 2011-09-06 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS
US7214818B2 (en) 2004-10-29 2007-05-08 Hoffmann-La Roche Inc. Method for synthesizing bisphosphonate
PL199215B1 (pl) * 2004-12-28 2008-08-29 Politechnika Gdanska Sposób wytwarzania kwasu [1-hydroksy-2-(3-pirydylo)etylidenobisfosfonowego] oraz jego soli monosodowej dwu i pół wodnej
EP1888606A2 (fr) * 2005-05-28 2008-02-20 PLIVA HRVATSKA d.o.o. Nouveau sel et procede associe
US7872144B2 (en) * 2005-06-13 2011-01-18 Jubilant Organosys Limited Process for producing biphosphonic acids and forms thereof
EP1775302A1 (fr) 2005-10-11 2007-04-18 Sandoz A/S Méthode pour la préparation de risedronate de sodium cristallin
US7768984B2 (en) 2006-01-06 2010-08-03 Samsung Electronics Co., Ltd Apparatus and method for receiving a signal in a communication system
CA2646334A1 (fr) * 2006-03-17 2007-09-27 The Board Of Trustees Of The University Of Illinois Composes de biphosphonates et procedes
JP5354858B2 (ja) * 2006-05-09 2013-11-27 株式会社Adeka スルホンアミド化合物の金属塩を含有するポリエステル樹脂組成物
BRPI0710421A2 (pt) 2006-05-11 2011-08-09 Ind Swift Ltd processo para a preparação de ácido risedrÈnico puro ou sais
PL2144919T3 (pl) 2007-04-11 2016-05-31 Hoffmann La Roche Wieloetapowa synteza ibandronianu
WO2008152518A2 (fr) * 2007-05-16 2008-12-18 Actavis Group Ptc Ehf Procédé de préparation du risédronate sodique
WO2009050731A2 (fr) * 2007-06-20 2009-04-23 Alkem Laboratories Ltd Procédé inédit de préparation de l'acide risédronique
KR100877667B1 (ko) * 2007-06-28 2009-01-08 보령제약 주식회사 리세드로네이트의 제조 방법
JP2011515535A (ja) * 2008-03-17 2011-05-19 キャボット コーポレイション リン酸塩遊離が低減した改質顔料、ならびにそれからの分散体およびインクジェットインク組成物
JP5258370B2 (ja) * 2008-05-08 2013-08-07 ダイト株式会社 リセドロン酸の工業的製造方法
CA2775004A1 (fr) 2009-10-02 2011-04-07 Straitmark Holding Ag Procede pour la fabrication d'acides aminohydroxydiphosphoniques

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2534391C2 (de) 1975-08-01 1983-01-13 Henkel KGaA, 4000 Düsseldorf 1-Hydroxy-3-aminoalkan-1,1-diphosphonsäuren
DE2658961C3 (de) 1976-12-24 1981-09-24 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen Verfahren zur Herstellung von 1-Hydroxy-3-amino-propan-1,1-diphosphonsäuren
US4447256A (en) 1977-07-20 1984-05-08 Nissan Chemical Industries, Ltd. N-(Unsubstituted or substituted pyridyl)aminomethylene-diphosphonic acids, herbicidal compositions containing same, their use for herbicides, and process for preparing same
DE2745083C2 (de) 1977-10-07 1985-05-02 Henkel KGaA, 4000 Düsseldorf Hydroxydiphosphonsäuren und Verfahren zu deren Herstellung
US4330537A (en) 1977-12-07 1982-05-18 The Procter & Gamble Company Compositions for inhibiting mobilization of calcium phosphate in animal tissue
JPS5598193A (en) 1979-01-22 1980-07-25 Nissan Chem Ind Ltd Methylenediphosphonic acid derivative and herbicide comprising it as active constituent
DE2943498C2 (de) 1979-10-27 1983-01-27 Henkel KGaA, 4000 Düsseldorf Verfahren zur Herstellung von 3-Amino-1-hydroxypropan-1,1-diphosphonsäure
DE3016289A1 (de) 1980-04-28 1981-10-29 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren
US4304734A (en) 1980-10-16 1981-12-08 Vysoka Skola Chemicko-Technologicka 6-Amino-1-hydroxyhexylidene diphosphonic acid, salts and a process for production thereof
DE3151038A1 (de) 1981-12-23 1983-07-28 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von 3-amino-1-hydroxypropan-1,1-diphosphonsaeure
IT1201087B (it) 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
IT1196315B (it) 1984-10-29 1988-11-16 Gentili Ist Spa Procedimento per la preparazione di acidi difosfonici
IL77243A (en) 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
IT1187750B (it) 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di compresse,anche a rilascio prolungato,di iscsorbide-5-mononitrato stabilizzato e formulazioni cosi' ottenute
DE3540150A1 (de) 1985-11-13 1987-05-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
GB8531071D0 (en) 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
DE3773716D1 (de) 1986-03-24 1991-11-21 Nippon Kayaku Kk Verfahren zur herstellung von monosodiumsalz und dessen monohydrat von 1-beta-d-arabinofuranosylcytosin-5'stearylphosphat und diese enthaltende pharmazeutische zusammensetzung.
DE3623397A1 (de) 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3626058A1 (de) 1986-08-01 1988-02-11 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
ATE72816T1 (de) 1986-11-21 1992-03-15 Ciba Geigy Ag Neue substituierte alkandiphosphonsaeuren.
DE3700772A1 (de) 1987-01-13 1988-07-21 Inst Khim Kinetiki I Gorenija Verfahren zur herstellung von i-funktionellsubstituierten alkyliden-i,i-diphosphonsaeuren und deren gemischen
US5091525A (en) 1987-10-07 1992-02-25 Eli Lilly And Company Monohydrate and DMF solvates of a new carbacephem antibiotic
US5035898A (en) 1987-11-27 1991-07-30 Schering Corporation Potassium/magnesium supplement
US5110807A (en) 1988-12-01 1992-05-05 Ciba-Geigy Corporation Araliphatylaminoalkanediphosphonic acids
DE3822650A1 (de) 1988-07-05 1990-02-01 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3917153A1 (de) 1989-05-26 1990-11-29 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
TW208013B (fr) 1990-03-01 1993-06-21 Daiichi Co Ltd
WO1992003451A1 (fr) 1990-08-21 1992-03-05 The Upjohn Company Derives d'acide bisphosphonique utilises comme agents anti-arthritiques
US5039819A (en) 1990-09-18 1991-08-13 Merck & Co., Inc. Diphosphonate intermediate for preparing an antihypercalcemic agent
IT1246992B (it) 1991-01-08 1994-12-12 Gentili Ist Spa Procedimento per la preparazione di acidi difosfonici e loro sali
DK58291D0 (da) 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling
SE501389C2 (sv) 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning
US5317015A (en) 1992-05-01 1994-05-31 Rhone-Poulenc Rorer Pharmaceuticals Inc. Azacyclic bisphosphonates as anticholesterolemic agents
ATE173267T1 (de) 1992-06-23 1998-11-15 Yamanouchi Pharma Co Ltd Neues kristall von heterozyclischen bis(phosphonsäure) monohydrat-derivat
FR2694558B1 (fr) 1992-08-05 1994-10-28 Sanofi Elf Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant.
US5312925A (en) 1992-09-01 1994-05-17 Pfizer Inc. Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride
EP0696292A1 (fr) 1993-04-28 1996-02-14 Pfizer Inc. Monohydrate cristallin glycosidique de spirostanyle
US5510517A (en) 1993-08-25 1996-04-23 Merck & Co., Inc. Process for producing N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic acids
US5580977A (en) 1995-03-01 1996-12-03 Eli Lilly And Company Process for preparing loracarbef monohydrate
TW393488B (en) 1995-04-20 2000-06-11 Merck & Co Inc Process for making 1-hydrox-ybisphosphonates
KR100192215B1 (ko) 1996-09-03 1999-06-15 강재헌 3-아미노-1-히드록시프로판-1,1-디포스폰산의 제조방법
CA2197267C (fr) 1997-02-11 2000-02-08 Yong Tao Procede pour la preparation de l'acide 4-amino-1-hydroxybutylidene-1,1-bisphosphonique ou de ses sels

Also Published As

Publication number Publication date
SK10992002A3 (sk) 2003-02-04
PL357116A1 (en) 2004-07-12
ES2221887T3 (es) 2005-01-16
HUP0300890A3 (en) 2009-01-28
EP1252169B1 (fr) 2004-06-16
PE20011065A1 (es) 2001-11-21
US6562974B2 (en) 2003-05-13
DE60103851T2 (de) 2005-06-23
CN1396925A (zh) 2003-02-12
NO20023646L (no) 2002-09-30
PL207617B1 (pl) 2011-01-31
CA2399974A1 (fr) 2001-08-09
BRPI0107952B1 (pt) 2015-09-01
RU2002123362A (ru) 2004-01-10
IL150512A (en) 2006-10-31
CZ304038B6 (cs) 2013-09-04
PT1252169E (pt) 2004-11-30
TR200402317T4 (tr) 2004-12-21
AU784385B2 (en) 2006-03-23
ATE269343T1 (de) 2004-07-15
NO330273B1 (no) 2011-03-14
JP2003522181A (ja) 2003-07-22
NO20023646D0 (no) 2002-07-31
BRPI0107952B8 (pt) 2021-05-25
MXPA02007418A (es) 2002-12-09
KR20020063622A (ko) 2002-08-03
NZ519967A (en) 2004-05-28
CA2399974C (fr) 2005-08-16
US20010041690A1 (en) 2001-11-15
CO5430222A1 (es) 2004-06-01
KR100681740B1 (ko) 2007-02-15
CN1223598C (zh) 2005-10-19
WO2001057052A1 (fr) 2001-08-09
HK1051045A1 (zh) 2003-07-18
BR0107952A (pt) 2003-02-25
JP4534185B2 (ja) 2010-09-01
AU3661301A (en) 2001-08-14
DE60103851D1 (de) 2004-07-22
EP1252169A1 (fr) 2002-10-30
HUP0300890A2 (hu) 2003-08-28
HU228980B1 (en) 2013-07-29
DK1252169T3 (da) 2004-10-25

Similar Documents

Publication Publication Date Title
IL150512A0 (en) Process for making geminal bisphosphonates
AU679859B2 (en) Novel compound, process for producing the same, and antitumor agent
ATE233779T1 (de) Tris(oxalato)phosphate, verfahren zu deren herstellung und deren verwendung
DE50104089D1 (de) Verfahren zur Herstellung von Ethan-1,2-bis(alkylphosphinsäuren)
ATE99314T1 (de) Verfahren zur herstellung von zweizaehnigen liganden.
DK1304362T3 (da) Carbonholdigt materiale
ES2038404T3 (es) Preparacion de ligandos bidentados.
Amedjkouh et al. Self-reproduction of chirality on α-aminophosphonates: Asymmetric synthesis of α-alkylated diethyl pyrrolidin-2-yl-phosphonate
ES8802158A1 (es) Un procedimiento para la preparacion de sales organicas de acidos fosfonicos.
GB9807104D0 (en) The preparation of phosphine ligands
DK0968189T3 (da) Fremgangsmåde til fremstilling af nicotinsyrer
BR9813923A (pt) N n - bis(sulfonil) hidrazinas úteis como agentes antineoplásicos
MY134246A (en) Diphosphine
DE68928127D1 (de) 2'-Methylidenpyrimidinnukleosidverbindungen, ihre Verwendung und Verfahren zu ihrer Herstellung
ES502073A0 (es) Metodo de producir lactamas antihipertensoras
TR199901474T2 (xx) �misazol t�revleri i�in proses.
Miao et al. A convenient two-step one-pot synthesis of alkylthiophosphoramidates derivatives
Yoshida et al. Preparation of 3, 3-Bis (phosphoryl) cyclopropenes.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed